Literature DB >> 25412485

[Infections caused by human alpha herpes viruses].

V Boštíková, M Salavec, J Smetana, R Sleha, M Coufalová, M Spliňo, P Boštík.   

Abstract

Varicella-zoster virus (VZV), herpes simplex virus one (HSV-1) and herpes simplex virus two (HSV-2) represent three out of the eight known human herpesviruses and belong to the subfamily of α-herpesviruses. These viruses are present worldwide and humans are their sole host and reservoir. After the primary infection, these viruses persist in the body throughout life. The period of latency may be interrupted by reactivation of infection due to various factors. Each virus can induce a wide spectrum of diseases. The primary infection is typical for children and otherwise healthy individuals are often asymptomatic. It is mainly immunocompromised patients who are at risk of developing severe disease or complications when infected by these viruses. However, even in otherwise healthy individuals an infection by a-herpesviruses can run a severe course and lead to death.

Entities:  

Mesh:

Year:  2014        PMID: 25412485

Source DB:  PubMed          Journal:  Epidemiol Mikrobiol Imunol        ISSN: 1210-7913            Impact factor:   0.444


  2 in total

Review 1.  Features and Functions of the Conserved Herpesvirus Tegument Protein UL11 and Its Binding Partners.

Authors:  Linjiang Yang; Mingshu Wang; Anchun Cheng; Qiao Yang; Ying Wu; Juan Huang; Bin Tian; Renyong Jia; Mafeng Liu; Dekang Zhu; Shun Chen; Xinxin Zhao; Shaqiu Zhang; Xumin Ou; Sai Mao; Qun Gao; Di Sun
Journal:  Front Microbiol       Date:  2022-06-03       Impact factor: 6.064

2.  Myricetin inhibits pseudorabies virus infection through direct inactivation and activating host antiviral defense.

Authors:  Huaiyue Hu; Zhiqiang Hu; Yingying Zhang; Hongping Wan; Zhongqiong Yin; Lixia Li; Xiaoxia Liang; Xinghong Zhao; Lizi Yin; Gang Ye; Yuan-Feng Zou; Huaqiao Tang; Renyong Jia; Yaqin Chen; Hao Zhou; Xu Song
Journal:  Front Microbiol       Date:  2022-09-15       Impact factor: 6.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.